Editorial
Prostate cancer: where are we and where are we going?
Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study
Familial prostate cancer studies in Utah
Cellular interactions in prostate cancer
Tumour-suppressor genes in prostatic oncogenesis: a positional approach
The cadherin cell-cell adhesion pathway in prostate cancer progression
Prostate-specific antigen: molecular forms and the human kallikrein gene family
Some comments on progress in the standardization of immunoassays for prostate-specific antigen
Prostate-specific antigen, clinical use and staging: an overview
Enhancing the specificity of prostate-specific antigen (PSA): an overview of PSA density, velocity and age-specific reference ranges
The European Randomized Study of Screening for Prostate Cancer(ERSPC)
The palliative therapy of advanced prostate cancer, with particular reference to the results of recent European clinical trials
Early detection of cancer relapse after prostatectomy using very sensitive prostate-specific antigen measurements
New diagnostic applications of prostate-specific antigen
Medical therapy for benign prostatic hyperplasia: the road ahead
Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen
Prostate-specific antigen in tissue from fine-needle aspiration biopsies
Prostatic cancer: future prospects for diagnosis and screening